This is a Validated Antibody Database (VAD) review about mouse Mlh1, based on 17 published articles (read how Labome selects the articles), using Mlh1 antibody in all methods. It is aimed to help Labome visitors find the most suited Mlh1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Mlh1 synonym: 1110035C23Rik; AI317206; AI325952; AI561766
Knockout validation
Santa Cruz Biotechnology mouse monoclonal (B-12) |
| Santa Cruz Biotechnology Mlh1 antibody (Santa Cruz, sc-271978) was used in western blot knockout validation on human samples (fig 4a). Cell Death Dis (2020) ncbi |
Abcam
domestic rabbit monoclonal (EPR3894) |
| Abcam Mlh1 antibody (Abcam, ab92312) was used in western blot on mouse samples (fig s1b). Front Genet (2022) ncbi |
domestic rabbit monoclonal (EPR3894) |
| Abcam Mlh1 antibody (Abcam, ab92312) was used in immunohistochemistry on mouse samples at 1:200 (fig 5a). Front Cell Dev Biol (2021) ncbi |
domestic rabbit monoclonal (EPR3894) |
| Abcam Mlh1 antibody (Abcam, ab92312) was used in western blot on human samples (fig s1). Aging (Albany NY) (2021) ncbi |
domestic rabbit monoclonal (EPR3894) |
| Abcam Mlh1 antibody (Abcam, ab92312) was used in immunohistochemistry on mouse samples at 1:500. JCI Insight (2020) ncbi |
mouse monoclonal (G168-15) |
| Abcam Mlh1 antibody (Abcam, ab14206) was used in immunocytochemistry on human samples (fig 2b). J Biol Chem (2019) ncbi |
domestic rabbit monoclonal (EPR3894) |
| Abcam Mlh1 antibody (Abcam, ab92312) was used in immunohistochemistry - frozen section on mouse samples at 1:1500 (fig 1a). Carcinogenesis (2018) ncbi |
domestic rabbit monoclonal (EPR3894) |
| Abcam Mlh1 antibody (Abcam, ab92312) was used in western blot on mouse samples (fig s4c). Cell (2018) ncbi |
domestic rabbit monoclonal (EPR3894) |
| Abcam Mlh1 antibody (Abcam, ab92312) was used in western blot on mouse samples (fig s4c). Cell (2018) ncbi |
domestic rabbit monoclonal (EPR3894) |
| In order to investigate the oncogenic functions of CHD4, Abcam Mlh1 antibody (Abcam, ab92312) was used in immunohistochemistry - paraffin section on human samples (fig s5e-h) and in western blot on human samples (fig s3a-b). Cancer Cell (2017) ncbi |
domestic rabbit monoclonal (EPR3894) |
| In order to outline the protocols for antibodies used for immunohistochemical studies, Abcam Mlh1 antibody (Abcam, ab92312) was used in immunohistochemistry - paraffin section on rat samples at 1:1600 (fig st11). J Toxicol Pathol (2017) ncbi |
mouse monoclonal (G168-15) |
| Abcam Mlh1 antibody (Abcam, ab14206) was used in immunocytochemistry on mouse samples at 1:20 (fig 1). PLoS Genet (2016) ncbi |
Santa Cruz Biotechnology
mouse monoclonal (B-12) |
| Santa Cruz Biotechnology Mlh1 antibody (Santa Cruz, sc-271978) was used in western blot knockout validation on human samples (fig 4a). Cell Death Dis (2020) ncbi |
BD Biosciences
mouse monoclonal (G168-728) |
| BD Biosciences Mlh1 antibody (BD, 554073) was used in western blot on human samples (fig 1s1c). elife (2019) ncbi |
mouse monoclonal (G168-728) |
| In order to characterize autophagy induction by thiopurines, BD Biosciences Mlh1 antibody (BD Pharmingen, 554073) was used in western blot on human samples (fig s1). Oncotarget (2016) ncbi |
mouse monoclonal (G168-728) |
| In order to discuss mechanisms involved in the resistance of androgen receptor-targeted therapies, BD Biosciences Mlh1 antibody (Abcam, 554073) was used in immunohistochemistry on human samples at 1:400 (fig s4b). Nat Med (2016) ncbi |
mouse monoclonal (G168-728) |
| BD Biosciences Mlh1 antibody (BD Pharmingen, G168-728) was used in immunohistochemistry on human samples at 1:100. JAMA Oncol (2016) ncbi |
mouse monoclonal (G168-728) |
| BD Biosciences Mlh1 antibody (BD Biosciences, G168-728) was used in immunoprecipitation on human samples and in western blot on human samples . Mol Cancer (2014) ncbi |
Articles Reviewed
- Taieb J, Zaanan A, Le Malicot K, Julie C, Blons H, Mineur L, et al. Prognostic Effect of BRAF and KRAS Mutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without Cetuximab: A Post Hoc Analysis of the PETACC-8 Trial. JAMA Oncol. 2016;2:643-653 pubmed publisher
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments